Mount Sinai Parkinson’s Expert Available
Mount Sinai Health System
A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center sheds light on testosterone recovery following androgen deprivation therapy in men undergoing radiotherapy for prostate cancer, providing key insights for optimizing patient care.
Researchers at the Johns Hopkins University School of Medicine have mapped variation in human stem cells that explains how cells of an individual may shape a unique “developmental dance” at the molecular level, thereby controlling how the brain and body are created.
A landmark study led by UCLA Health has begun to unravel one of the fundamental mysteries in neuroscience – how the human brain encodes and makes sense of the flow of time and experiences.
Case Western Reserve University School of Medicine identifies a potential new approach to address the opioid overdose epidemic—which has devastated families and communities nationally. Semaglutide was found to lower opioid overdoses in people with opioid-use disorder (OUD) and type 2 diabetes (T2D).
The American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) proudly announces Dr. Marianne de Visser as the 2024 Honorary Member Award recipient for her dedication to her students, patients, and research.
The PdNHF has long been a trusted partner of Texas Tech Health El Paso, focused on leading, investing in, and supporting programs that promote health and prevent disease in our Borderplex region. The $5 million grant will be instrumental in elevating comprehensive cancer care by funding the recruitment of top-tier cancer specialists. This ensures the future center will be equipped to deliver expert care from its inception. Dr. Lange called it a foundational grant because it’s a cornerstone of the funding for the future Fox Cancer Center, emphasizing that through collective strength and action – the power of people – we can bring hope to members of our Borderplex community.
The development of versatile and efficient biocatalysts for the synthesis of α-hydroxyketones and Ephedra-type alkaloids represents a significant advancement in synthetic biology and medicinal chemistry. In this study, researchers explore the potential of acetolactate synthase (AlsS) from Bacillus subtilis (BsAlsS) for the production of phenylacetylcarbinol (PAC) and its derivatives. Additionally, the study investigates the use of intermediate reductive amination enzymes (introduction of amine group using enzymes) for functionalizing α-hydroxyketones to generate synthetic Ephedra-type alkaloids.
Douglas Terry, PhD, a neuropsychologist at Vanderbilt University Medical Center, will work with the National Football League (NFL) as the Senior Director of Research.
Researchers from China have achieved a breakthrough in biofuel production with the development of Rhodococcus aetherivorans strain N1, a new species, and its enhanced variant, N1-S. The study highlights how N1-S excels at detoxifying toxic byproducts from lignocellulosic biomass, resulting in a remarkable 6.5-fold increase in succinic acid yields compared to traditional methods.
Rutgers Health research finds the medications of grandparents and pets, as well as discarded items, pose unexpected hazards for young children.
Concussions, meniscus tears and ankle sprains can happen to any athlete. But not every athlete has an army of sports medicine experts behind them. Four Penn State Health experts discuss common sports injuries among athletes and what you can do to prevent them.
Hackensack Meridian Health’s Men’s Health Day Offers Screenings for Those at High Risk for Prostate Cancer & Other Diseases
The University of Pittsburgh Schools of the Health Sciences has been awarded approximately $100 million from the U.S. Department of Defense to continue a clinical research program that is advancing trauma care.
Regener-Eyes®, a leader in ophthalmic solutions, is proud to announce the launch of our new multi-dose bottle, designed specifically for use with our preservative-free eye drops. This innovative packaging marks a major milestone in continuing to provide safe, sterile, and user-friendly eye care solutions.
Over 90 percent of people around the world are exposed to unhealthy air, according to the World Health Organization. In 2019, ambient air pollution was responsible for 4.2 million premature deaths. That’s roughly the number of people who visit Manhattan on a typical weekday.
Mount Sinai Health System, a leading health system in the United States and one of the largest in the New York City area, and Noom, the leading digital health care company committed to chronic disease prevention and empowering people to live better and healthier lives, have partnered to provide patients with a whole-person approach to healthy, long-lasting weight loss.
A new review highlights the potential of CRISPR–Cas13 for RNA-editing therapies. Discussing the advantages of the effector protein Cas13 over Cas9, they report that CRISPR–Cas13 facilitates RNA knockdown, RNA silencing, RNA splicing, RNA-base editing, and translation regulation. CRISPR–Cas13 has diverse applications like virus detection, antivirus vaccines, and personalized therapies. Additionally, they also discuss the role of AI in enabling the realization of the full potential of RNA-editing technologies.
People having surgery on mitral and tricuspid heart valves may receive a pacemaker more often than necessary — leading to a greater risk for life-threatening complications, studies show. Researchers say high volume hospitals with experienced surgeons may be able to achieve similar outcomes without needing to implant the device.